[1]
Hamidah, M., Widyawaruyanti, A., Widjiati, W. and Prasetyo, B. 2018. Sambiloto (AS201-01) is better than standard antimalarial drug (DHP) in reducing Toll-Like Receptor 2 (TLR2) on placenta malaria model. Majalah Obstetri & Ginekologi. 26, 2 (Aug. 2018), 74–82. DOI:https://doi.org/10.20473/mog.V26I22018.74-82.